FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to tissue engineering, combustiology, transplantology, cosmetology, and discloses a bioplastic porous material based on a soluble form of a stabilized extracellular matrix. Bioplastic material is characterized by that it has thickness of 0.1–3 cm, is maximally close to physiological parameters of skin derma, consists of three-molecule crossed strands of extracellular matrix and is enriched with a composition containing type I collagen, hyaluronic acid, elastin, as well as biologically active components representing human neonatal fibroblasts in DMEM medium with addition of FBS, L-glutamine, penicillin, streptomycin. Biomaterial has biological compatibility, increasing proliferative potential of cells, enabling organ-specific tissue repair and can act as a biodegradable scaffold.
EFFECT: bioplastic material can be used as biomaterial for stimulation of regeneration and replacement of defects of investing tissues.
1 cl, 2 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| BIOLOGICALLY ACTIVE MATERIAL FOR COVERING WOUND SURFACES | 2022 |
|
RU2804197C1 |
| METHOD OF RECOVERY OF DEFECTS OF COVERING TISSUES | 2016 |
|
RU2644306C1 |
| MICRO-NANOSTRUCTURED BIOPLASTIC MATERIAL | 2012 |
|
RU2481127C1 |
| HISTO-EQUIVALENT BIOPLASTIC MATERIAL | 2013 |
|
RU2513838C1 |
| BIOTRANSPLANT FOR TREATMENT OF DEGENERATIVE AND TRAUMATIC DISEASE OF CARTILAGE TISSUE AND METHOD FOR ITS PREPARING | 2005 |
|
RU2301677C1 |
| METHOD FOR MANUFACTURING CELL-FREE MATRIX FROM HUMAN UMBILIC CORD TO CREATE HIGHLY GENERATIVE WOUND COVERING | 2022 |
|
RU2795904C1 |
| METHOD OF SEPARATING FIBROBLASTS, METHOD OF CREATING THEREOF-BASED BIOTRANSPLANT (VERSIONS) AND METHOD OF REGENERATING HUMAN TISSUES (VERSIONS) | 2013 |
|
RU2567004C2 |
| POLYSACCHARIDE COMPOSITIONS FOR RESTORING TISSUES | 2017 |
|
RU2760358C2 |
| METHOD OF TREATING COSMETIC SKIN DEFECTS | 2024 |
|
RU2831472C1 |
| NANOSTRUCTURED BIOPLASTIC MATERIAL | 2010 |
|
RU2425694C1 |
